26-Dec-2025
No headlines found.
No press releases found.
No news found.
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Invesco Pharmaceuticals ETF trades on the ARCA stock market under the symbol PJP.
As of December 26, 2025, PJP stock price declined to $107.85 with 5,259 million shares trading.
PJP has a market cap of $324.63 million. This is considered a Small Cap stock.
In the last 3 years, PJP traded as high as $108.40 and as low as $67.75.
PJP has outperformed the market in the last year with a price return of +30.2% while the SPY ETF gained +16.0%. PJP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +18.7% and +2.1%, respectively, while the SPY returned +4.6% and +1.5%, respectively.
PJP support price is $107.21 and resistance is $108.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PJP shares will trade within this expected range on the day.
